SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Disciplined Investing, especially the NAIC way

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: - with a K who wrote (324)5/9/2002 7:59:56 PM
From: The Philosopher  Read Replies (1) of 469
 
I don't know PRX -- is it still worth looking at?

We held WPI and did quite well with it until it decided to go into brand drugs. At that point we sold it, since we had no track record of the company as a brand name company to base an evaluation on.

The problem I see with generic makers is that it's all based on price competition. They all have to comply with the same formularies and regulations, so prices can really get cut to the bone. And there's still a huge potential liability if a batch gets messed up.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext